(S (NP (NNS Studies)) (VP (VBP estimate) (SBAR (IN that) (S (NP (EX there)) (VP (MD will) (VP (VB be) (NP (NP (NP (CD 266,120) (JJ new) (NNS cases)) (PP (IN of) (NP (JJ invasive) (NN breast) (NN cancer)))) (CC and) (NP (CD 40,920) (ADJP (NN breast) (NN cancer) (VBD induced)) (NNS deaths))) (PP (IN in) (NP (NP (DT the) (NN year)) (PP (IN of) (NP (CD 2018))) (ADVP (NN alone))))))))) (. .))
(S (PP (IN Despite) (NP (NP (DT the) (NN pervasiveness)) (PP (IN of) (NP (DT this) (NN affliction))))) (, ,) (NP (NP (DT the) (JJ current) (NN process)) (SBAR (S (VP (TO to) (VP (VB obtain) (NP (DT an) (JJ accurate) (NN breast) (NN cancer) (NN prognosis))))))) (VP (VBZ is) (ADJP (ADJP (JJ tedious)) (CC and) (ADJP (NN time) (NN consuming))) (, ,) (S (VP (VBG requiring) (S (NP (DT a) (JJ trained) (NN pathologist)) (VP (TO to) (VP (ADVP (RB manually)) (VB examine) (NP (JJ histopathological) (NNS images)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBP characterize) (NP (JJ various) (NN cancer) (NN severity) (NNS levels)))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP propose) (NP (NP (JJ MITOS-RCNN)) (: :) (NP (NP (DT a) (JJ novel) (ADJP (NN region) (VBN based)) (JJ convolutional) (JJ neural) (NN network)) (PRN (-LRB- -LRB-) (NP (NNP RCNN)) (-RRB- -RRB-)) (VP (VBD geared) (PP (IN for) (NP (JJ small) (JJ object) (NN detection))) (S (VP (TO to) (VP (ADVP (RB accurately)) (VB grade) (NP (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (CD three) (NNS factors)) (SBAR (WHNP (IN that)) (S (VP (VBP characterize) (NP (NP (NN tumor) (NN belligerence)) (VP (VBN described) (PP (IN by) (NP (DT the) (NNP Nottingham) (NNP Grading) (NNP System))))))))))) (: :) (NP (JJ mitotic) (NN count)))))))))) (. .))
(S (NP (NP (JJ Other) (JJ computational) (NNS approaches)) (PP (TO to) (NP (JJ mitotic) (NN figure) (NN counting) (CC and) (NN detection)))) (VP (VBP do) (RB not) (VP (VB demonstrate) (NP (JJ ample) (NN recall) (CC or) (NN precision)) (S (VP (TO to) (VP (VB be) (ADJP (RB clinically) (JJ viable))))))) (. .))
(S (NP (PRP$ Our) (NNS models)) (VP (VBN outperformed) (NP (NP (DT all) (JJ previous) (NNS participants)) (PP (IN in) (NP (NP (NP (DT the) (NNP ICPR) (CD 2012) (NN challenge)) (, ,) (NP (DT the) (NNP AMIDA) (CD 2013) (NN challenge)) (CC and) (NP (DT the) (NNP MITOS-ATYPIA-14) (NN challenge))) (PP (IN along) (PP (IN with) (NP (ADJP (RB recently) (VBN published)) (NNS works)))))))) (. .))
(S (NP (PRP$ Our) (NN model)) (VP (VBD achieved) (NP (NP (NP (DT an) (JJ F-measure) (NN score)) (PP (IN of) (NP (CD 0.955)))) (, ,) (NP (NP (DT a) (ADJP (CD 6.11) (NN %)) (NN improvement)) (PP (IN in) (NP (NN accuracy))) (PP (IN from) (NP (NP (DT the) (ADJP (RBS most) (JJ accurate))) (PP (IN of) (NP (DT the) (ADJP (RB previously) (VBN proposed)) (NNS models)))))))) (. .))
